clinical trial · NCT06066645
Travoprost Intraocular Implant + iStent Infinite
Glaucoma, Open-AngleTravoprost Intraocular ImplantiStent infiniteSham procedure
brief summary
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
started
Sep 14, 2023
primary completion
May 1, 2027
completion
Feb 1, 2028
last updated
Jun 2, 2026
official title
Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite in Subjects With Open-angle Glaucoma or Ocular Hypertension
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol